Advanced

The potential of proton beam radiation therapy in intracranial and ocular tumours

Blomquist, E; Bjelkengren, Göran LU and Glimelius, B (2005) In Acta Oncologica 44(8). p.862-870
Abstract
A group of oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the doseresponse relations of different tumours and normal tissues. In intracranial benign and malignant tumours, it is estimated that between 130 and 180 patients each year are candidates for proton beam therapy. Of these, between 50 and 75 patients have malignant glioma, 30-40 meningeoma, 20-25 arteriovenous malformations, 20-25 skull base tumours and 10-15 pituitary adenoma. In... (More)
A group of oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the doseresponse relations of different tumours and normal tissues. In intracranial benign and malignant tumours, it is estimated that between 130 and 180 patients each year are candidates for proton beam therapy. Of these, between 50 and 75 patients have malignant glioma, 30-40 meningeoma, 20-25 arteriovenous malformations, 20-25 skull base tumours and 10-15 pituitary adenoma. In addition, 15 patients with ocular melanoma are candidates. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Acta Oncologica
volume
44
issue
8
pages
862 - 870
publisher
Taylor & Francis
external identifiers
  • wos:000233855500009
  • pmid:16332593
  • scopus:28844478883
ISSN
1651-226X
DOI
10.1080/02841860500355934
language
English
LU publication?
yes
id
d24d5e29-3807-4586-b33f-0de919e1f62a (old id 894351)
date added to LUP
2008-01-11 11:57:33
date last changed
2017-01-01 07:17:54
@article{d24d5e29-3807-4586-b33f-0de919e1f62a,
  abstract     = {A group of oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the doseresponse relations of different tumours and normal tissues. In intracranial benign and malignant tumours, it is estimated that between 130 and 180 patients each year are candidates for proton beam therapy. Of these, between 50 and 75 patients have malignant glioma, 30-40 meningeoma, 20-25 arteriovenous malformations, 20-25 skull base tumours and 10-15 pituitary adenoma. In addition, 15 patients with ocular melanoma are candidates.},
  author       = {Blomquist, E and Bjelkengren, Göran and Glimelius, B},
  issn         = {1651-226X},
  language     = {eng},
  number       = {8},
  pages        = {862--870},
  publisher    = {Taylor & Francis},
  series       = {Acta Oncologica},
  title        = {The potential of proton beam radiation therapy in intracranial and ocular tumours},
  url          = {http://dx.doi.org/10.1080/02841860500355934},
  volume       = {44},
  year         = {2005},
}